Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NTRA · against 57 other Healthcare companies of similar size
Ranked #55 of 58 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score4 peers with a valuation score of 0–9, including NTRA · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | NTRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 55 reported | -0.4% | 2.9% | 6% | 30% | |
| EBITDA yieldHigher is better · 59 reported | -0.4% | 6.1% | 3% | 50% | |
| Free cash flow yieldHigher is better · 42 reported | 0.1% | 3.7% | 5% | 20% | |
| Book yieldHigher is better · 54 reported | 3.3% | 21.1% | 9% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 108.6B USD | 88 | 66 | |
| 4 | 97.5B USD | 87 | 67 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 53 | 2.67T INR (≈$32.1B) | 39 | 68 | |
| 54 | 45.2B USD | 38 | 46 | |
| 55 | 33.3B USD | 8 | 24 | |
| 55 | 91.2B USD | 8 | 18 | |
| 55 | 56.0B USD | 8 | 39 | |
| 55 | 41.6B USD | 8 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score